Huang Yi-Wenn Yvonne, Alleyne Alison, Leung Vivian, Chapman Michael
, BSc(Pharm), ACPR, is with the Pharmacy Department, Surrey Memorial Hospital, Surrey, British Columbia.
, BScPhm, PharmD, is with the Pharmacy Department, Surrey Memorial Hospital, Surrey, British Columbia.
Can J Hosp Pharm. 2018 Mar-Apr;71(2):119-127. Epub 2018 Apr 30.
Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae are pathogens that are implicated in urosepsis and may be associated with greater morbidity and mortality than non-ESBL Enterobacteriaceae. Identification of risk factors for ESBL infection may facilitate the selection of appropriate empiric therapy.
The primary objectives were to determine the cumulative incidence of ESBL urosepsis, to identify major risk factors for ESBL urosepsis, and to determine the impact of international travel on development of ESBL urosepsis in an ethnically diverse Canadian population. The secondary objective was to characterize the outcomes of patients with ESBL urosepsis.
A single-centre retrospective nested case-control study was conducted from January 2011 to June 2013. The study cohort consisted of adult patients with urosepsis and positive results on blood culture for ESBL-producing and non-ESBL-producing Enterobacteriaceae. Multivariate analysis was then used to determine risk factors for ESBL urosepsis.
The cumulative incidence of ESBL urosepsis at the study site was 19.4% (58/299) over 2.5 years. The 58 cases of ESBL urosepsis were compared with 118 controls (patients with urosepsis caused by non-ESBL Enterobacteriaceae). Significant predictors of ESBL urosepsis were chronic renal insufficiency (odds ratio [OR] 4.66, 95% confidence interval [CI] 1.96-11.08; < 0.001) and travel to an endemic region in the previous 6 months (OR 4.62, 95% CI 1.17-18.19; = 0.029), as well as Punjabi or Hindi as the primary language (OR 3.25, 95% CI 1.45-7.29; = 0.004) and male sex (OR 2.65, 95% CI 1.21-5.80; = 0.015). Patients with ESBL urosepsis had worse prognosis-in terms of death or discharge with palliative measures only-than those with non-ESBL urosepsis (7/58 [12.1%] versus 4/118 [3.4%]; = 0.042).
Institution-specific data support prompt recognition of patients at risk for ESBL infections. Chronic renal insufficiency, recent travel to regions endemic for ESBL-producing organisms, primary language of Punjabi or Hindi, and male sex were the strongest risk factors for ESBL urosepsis at the study centre. However, findings from this single-centre study may not be generalizable to other institutions.
产超广谱β-内酰胺酶(ESBL)的肠杆菌科细菌是引起泌尿道感染的病原体,与非产ESBL肠杆菌科细菌相比,可能导致更高的发病率和死亡率。识别ESBL感染的危险因素有助于选择合适的经验性治疗方案。
主要目的是确定ESBL泌尿道感染的累积发病率,识别ESBL泌尿道感染的主要危险因素,并确定国际旅行对加拿大不同种族人群中ESBL泌尿道感染发生的影响。次要目的是描述ESBL泌尿道感染患者的结局。
2011年1月至2013年6月进行了一项单中心回顾性巢式病例对照研究。研究队列包括患有泌尿道感染且血培养结果为产ESBL和非产ESBL肠杆菌科细菌阳性的成年患者。然后使用多变量分析来确定ESBL泌尿道感染的危险因素。
在2.5年的研究期间,研究地点ESBL泌尿道感染的累积发病率为19.4%(58/299)。将58例ESBL泌尿道感染病例与118例对照(由非产ESBL肠杆菌科细菌引起泌尿道感染的患者)进行比较。ESBL泌尿道感染的显著预测因素为慢性肾功能不全(比值比[OR]4.66,95%置信区间[CI]1.96-11.08;P<0.001)、前6个月前往流行地区旅行(OR 4.62,95%CI 1.17-18.19;P=0.029)、以旁遮普语或印地语为主要语言(OR 3.25,95%CI 1.45-7.29;P=0.004)以及男性(OR 2.65,95%CI 1.21-5.80;P=0.015)。与非ESBL泌尿道感染患者相比,ESBL泌尿道感染患者的预后更差(仅采取姑息措施死亡或出院方面)(7/58[12.1%]对4/118[3.4%];P=0.042)。
特定机构的数据支持及时识别有ESBL感染风险的患者。慢性肾功能不全、近期前往产ESBL生物体流行地区旅行、主要语言为旁遮普语或印地语以及男性是研究中心ESBL泌尿道感染的最强危险因素。然而,这项单中心研究的结果可能不适用于其他机构。